These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8906310)

  • 1. Kynurenine-3-hydroxylase and its selective inhibitors. Molecular modeling studies.
    Costantino G; Mattoli L; Moroni F; Natalini B; Pellicciari R
    Adv Exp Med Biol; 1996; 398():493-7. PubMed ID: 8906310
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase.
    Pellicciari R; Amori L; Costantino G; Giordani A; Macchiarulo A; Mattoli L; Pevarello P; Speciale C; Varasi M
    Adv Exp Med Biol; 2003; 527():621-8. PubMed ID: 15206781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine hydroxylase and kynureninase inhibitors as tools to study the role of kynurenine metabolites in the central nervous system.
    Moroni F; Carpenedo R; Chiarugi A
    Adv Exp Med Biol; 1996; 398():203-10. PubMed ID: 8906267
    [No Abstract]   [Full Text] [Related]  

  • 4. Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo.
    Wu HQ; Guidetti P; Goodman JH; Varasi M; Ceresoli-Borroni G; Speciale C; Scharfman HE; Schwarcz R
    Neuroscience; 2000; 97(2):243-51. PubMed ID: 10799756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzoylalanine analogues as inhibitors of rat brain kynureninase and kynurenine 3-hydroxylase.
    Giordani A; Corti L; Cini M; Marconi M; Pillan A; Ferrario R; Schwarcz R; Guidetti P; Speciale C; Varasi M
    Adv Exp Med Biol; 1996; 398():499-505. PubMed ID: 8906311
    [No Abstract]   [Full Text] [Related]  

  • 6. Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents.
    Speciale C; Cini M; Wu HQ; Salvati P; Schwarcz R; Molinari A; Calabresi M; Varasi M
    Adv Exp Med Biol; 1996; 398():221-7. PubMed ID: 8906269
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage.
    Moroni F; Carpenedo R; Cozzi A; Meli E; Chiarugi A; Pellegrini-Giampietro DE
    Adv Exp Med Biol; 2003; 527():127-36. PubMed ID: 15206725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiospecific synthesis and in vitro activity of selective inhibitors of rat brain kynureninase and kynurenine-3-hydroxylase.
    Giordani A; Corti L; Cini M; Bormetti R; Marconi M; Veneroni O; Speciale C; Varasi M
    Adv Exp Med Biol; 1996; 398():531-4. PubMed ID: 8906317
    [No Abstract]   [Full Text] [Related]  

  • 9. 28833, a selective kynurenine 3-hydroxylase inhibitor. Effects on the kynurenine pathway metabolites in the gerbil.
    Cini M; Bormetti R; Marconi M; Molinari A; Veneroni O; Varasi M; Schwarcz R; Speciale C
    Adv Exp Med Biol; 1996; 398():535-8. PubMed ID: 8906318
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia.
    Moroni F; Cozzi A; Peruginelli F; Carpenedo R; Pellegrini-Giampietro DE
    Adv Exp Med Biol; 1999; 467():199-206. PubMed ID: 10721057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of 4-aryl-2-hydroxy-4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: potent inhibitors of kynurenine-3-hydroxylase as potential neuroprotective agents.
    Drysdale MJ; Hind SL; Jansen M; Reinhard JF
    J Med Chem; 2000 Jan; 43(1):123-7. PubMed ID: 10633043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.
    Röver S; Cesura AM; Huguenin P; Kettler R; Szente A
    J Med Chem; 1997 Dec; 40(26):4378-85. PubMed ID: 9435907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolo[3,2-c]quinoline derivatives: a new class of kynurenine-3-hydroxylase inhibitors.
    Heidempergher F; Pevarello P; Pillan A; Pinciroli V; Della Torre A; Speciale C; Marconi M; Cini M; Toma S; Greco F; Varasi M
    Farmaco; 1999 Mar; 54(3):152-60. PubMed ID: 10371028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsonii.
    Phillips RS; Anderson AD; Gentry HG; Güner OF; Bowen JP
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1705-1708. PubMed ID: 28302400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase.
    Giordani A; Pevarello P; Cini M; Bormetti R; Greco F; Toma S; Speciale C; Varasi M
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2907-12. PubMed ID: 9873646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase.
    Chiarugi A; Carpenedo R; Moroni F
    J Neurochem; 1996 Aug; 67(2):692-8. PubMed ID: 8764597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.
    Pellicciari R; Natalini B; Costantino G; Mahmoud MR; Mattoli L; Sadeghpour BM; Moroni F; Chiarugi A; Carpenedo R
    J Med Chem; 1994 Mar; 37(5):647-55. PubMed ID: 8126705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.
    Cozzi A; Carpenedo R; Moroni F
    J Cereb Blood Flow Metab; 1999 Jul; 19(7):771-7. PubMed ID: 10413032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia.
    Richter A; Hamann M
    Eur J Pharmacol; 2003 Sep; 478(1):47-52. PubMed ID: 14555184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound.
    Chiarugi A; Rapizzi E; Moroni F; Moroni F
    FEBS Lett; 1999 Jun; 453(1-2):197-200. PubMed ID: 10403402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.